نتایج جستجو برای: sustained virologic response svr

تعداد نتایج: 1046149  

Journal: :Kidney International Reports 2023

Hepatitis C positive patients were traditionally not considered suitable donor candidates in Malaysia. This perception shifted with the introduction of direct-acting antiviral agent (DAA), which demonstrated excellent sustained virologic response (SVR) post treatment. Furthermore, it has been established that potential risk death on wait list outweighs viral transmission.

Journal: :hepatitis monthly 0
huy a tran xu~ o~og{eserw}koloohezwowe~ jo{~i un e~okowtivao number 1, hunter mail region centre, australia +61-249214005, [email protected]; xu~ o~og{eserw}koloohezwowe~ jo{~i un

background: single nucleotide polymorphism in the interleukin28b (il28b) gene was recently shown to be associated with a significant increase in response to interferon-α and ribavirin treatment in patients with chronic hepatitis c. similarly, thyroid disease (td) occurring during treatment confer an improved sustained virologic response (svr). objectives: to determine the role of il28b genotype...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه تربیت مدرس - دانشکده پزشکی 1391

مقدمه: ویروس هپاتیت c متعلق به خانواده فلاوی ویریده و از جنس هپاسی ویروس می باشد که عامل بیماری مزمن کبدی در درصدی از افراد مبتلا می باشد. بیماران مبتلا به فرم مزمن بیماری هپاتیت c آلوده شده با ژنوتیپ 1 و 3 برای 48 هفته و ژنوتیپ 2 و 4 برای 24 هفته تحت درمان با انترفرون آلفا و ریباویرین قرار می گیرند. و پس از آن سرم از نظر ژنوم ویروس مورد ارزیابی قرار می گیرد که درصورت منفی شدن سرم از نظر ژنوم، ...

2011
Shiying Li Peng Hu Qin-Qin Zhang Ying-Hong Liu Huai-Dong Hu Da-Zhi Zhang Hong Ren

BACKGROUND Hepatitis C is a global health problem and represents a major cause of liver disease and socioeconomic burden. Effective antiviral therapy may prevent these complications, but the current treatment for patients with chronic hepatitis C virus (HCV) infection does not produce sustained virologic response. Therefore, identification of the determinants of response to treatment is a high ...

2009
Jung Hyun Kwon Si Hyun Bae Jong Young Choi Seung Kew Yoon Kwan Soo Byun Seung Woon Paik Young Suk Lim Han Chu Lee Kwang Hyub Han Kwan Sik Lee

BACKGROUND/AIMS The virologic response of Koreans to combination therapy for chronic hepatitis C is similar to westerns; however, dose modification occurs more frequently in Koreans. We evaluated the rates of peginterferon alpha-2a and ribavirin dose modifications and their effect on the virologic response in Koreans. METHODS Patients with detectable HCV RNA and enrolled from multicenters wer...

Journal: :Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2016
Zaigham Abbas Javed Yakoob Muhammad A Umer Ali A Azeem Saeed S Hamid Wasim Jafri

OBJECTIVE To assess the role of single nucleotide polymorphisms (SNPs) near the interferon lambda-3 (IFNλ3) (formal IL-28B) gene rs12979860 in predicting sustained virologic response (SVR) in hepatitis-C virus genotype-3 (HCV-3). STUDY DESIGN Descriptive, analytical study. PLACE AND DURATION OF STUDY Department of Medicine, The Aga Khan University Hospital, Karachi, from July 2012 to June 2...

2010
Dimitrios Dimitroulopoulos Ioannis Elefsiniotis Christos Pavlidis Dimitrios Xinopoulos Klisthenis Tsamakidis Stamatina Patsavela Dimitrios Kypreos Ageliki Ferderigou Dimitrios Korkolis Sotirios Koutsounas Georgios Saroglou Emmanouil Paraskevas

BACKGROUND AND AIMS Despite the recent spread of hepatitis C virus genotype 4 (HCV-4) into European countries, very little is known about the influence of ethnicity on treatment outcomes in patients with HCV-4. The aim of this study was to compare the virologic response (VR) rates of: rapid virologic response (RVR), early virologic response (EVR), VR at 24 weeks of treatment, at end of treatmen...

2011
Kyung-Ah Kim

A Sustained virologic response is durable in patients with chronic hepatitis C with peginterferon alfa-2a and ribavirin. The current standard therapy for chronic hepatitis C virus (HCV) infection is the combination of pegylated interferon and ribavirin. The ultimate goal of treatment in patients with chronic HCV infection is to completely eradicate HCV in infected hosts, and prevent liver-relat...

2016
Ming-Ying Lu Ching-I Huang Ming-Yen Hsieh Tusty-Juan Hsieh Edward Hsi Pei-Chien Tsai Yi-Shan Tsai Ching-Chih Lin Meng-Hsuan Hsieh Po-Cheng Liang Yi-Hung Lin Nai-Jen Hou Ming-Lun Yeh Chung-Feng Huang Zu-Yau Lin Shinn-Cherng Chen Jee-Fu Huang Wan-Long Chuang Chia-Yen Dai Ming-Lung Yu

Hepatitis C virus (HCV) can replicate in peripheral blood mononuclear cells (PBMCs), which can produce interferon to defend against virus infection. We hypothesized that dynamic gene expression in PBMCs might impact the treatment efficacy of peginterferon/ribavirin in HCV patients. PBMCs were collected at baseline, 1st week and 4th week of treatment from 27 chronic HCV-1 patients with 48-week p...

2011
Glenn Wagner Karen Chan Osilla Jeffrey Garnett Bonnie Ghosh-Dastidar Laveeza Bhatti Matthew Bidwell Goetz Mallory Witt

Background. Hepatitis C (HCV) treatment efficacy among HIV patients is limited by poor treatment adherence and tolerance, but few studies have examined the psychosocial determinants of treatment adherence and outcomes. Methods. Chart abstracted and survey data were collected on 72 HIV patients who had received pegylated interferon and ribavirin to assess correlates of treatment adherence, compl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید